Clinical Trials Directory

Trials / Conditions / Invasive Fungal Infection

Invasive Fungal Infection

19 registered clinical trials studyying Invasive Fungal Infection — 3 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingOutcomes From Hyperbaric Oxygen (HBO2) Treatment for Emerging Indications
NCT07240649
Jay C. Buckey Jr.Phase 4
RecruitingStudy to Assess the Safety and Efficacy of Intravenous BSG005 in Patients With Invasive Fungal Infection
NCT06678113
Biosergen ASPhase 1 / Phase 2
RecruitingPosaconazole (MK-5592) Intravenous and Oral in Children (<2 Years) With Invasive Fungal Infection (MK-5592-127
NCT04665037
Merck Sharp & Dohme LLCPhase 2
UnknownFactors on Therapeutic Drug Monitoring and Safety of Voriconazole in Critically Ill Elderly Patients
NCT06137690
People's Hospital of Zhengzhou University—
CompletedAn Individualized Administration Research of Voriconazole Based on CYP2C19 Gene Polymorphism and TDM
NCT04004078
People's Hospital of Zhengzhou University—
CompletedRegistry of Patients Treated With Systemic Mold-Active Triazoles
NCT03066011
Astellas Pharma Global Development, Inc.—
UnknownPharmacokinetics and Pharmacodynamics of Caspofungin (Cancidas ®) and Drug Tolerance of Fungi to Patients With
NCT02510053
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityN/A
CompletedAntifungal Prophylaxis With Micafungin After Cord Blood Allogeneic Stem Cell Transplantation (MycaCOORD)
NCT01888458
Nantes University HospitalPhase 2
CompletedPharmacokinetics of Micafungin in Patients Intensive Care Unit
NCT01783379
Radboud University Medical Center—
CompletedPharmacokinetics of Caspofungin (Cancidas ®) Given Intravenously as Therapy to Patients With an Invasive Funga
NCT01533558
Radboud University Medical Center—
CompletedProspective Clinical Evaluation of Beta-D-Glucan Assay in Blood and BAL
NCT01576653
Robert Krause, MDN/A
UnknownAssociation of Plasma Transfusions and Invasive Fungal Infection
NCT03149562
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University—
WithdrawnVoriconazole Plasma Level in Intensive Care Unit (ICU) Patients
NCT01185405
Asan Medical CenterN/A
TerminatedVoriconazole Trough Plasma Levels : Genetic Polymorphism, Efficacy, Safety in Patients With Hematologic Malign
NCT01148160
Asan Medical Center—
CompletedPharmacologic Optimization of Voriconazole
NCT00893555
Jan-Willem C AlffenaarPhase 3
CompletedEfficacy of Itraconazole as Secondary Prophylaxis in Patients Undergoing Allogeneic Stem Cell Transplantation
NCT01198236
Zhejiang UniversityPhase 4
UnknownEvaluate Three Methods for Diagnosis of Invasive Fungal Infection in Chinese Patients After HSCT
NCT00460330
Peking University—
CompletedIsavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis
NCT00412893
Astellas Pharma IncPhase 3
CompletedStudy of the Level of a Protein Which Could Predict the Development of a Fungal Infection in Patients With Acu
NCT02823132
Centre Hospitalier Universitaire Dijon—